Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome

Abstract Acute respiratory distress syndrome (ARDS) is a devastating hypoxemic respiratory failure, characterized by disruption of the alveolar-capillary membrane barrier. Current management for ARDS remains supportive, including lung-protective ventilation and a conservative fluid strategy. Mesench...

Full description

Bibliographic Details
Main Authors: Jibin Han, Yuxiang Liu, Hong Liu, Yuanyuan Li
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Stem Cell Research & Therapy
Subjects:
Acute lung injury (ALI)
Acute respiratory distress syndrome (ARDS)
Mesenchymal stem cells (MSCs)
Gene therapy
Genetic modification
Online Access:https://doi.org/10.1186/s13287-019-1518-0

Internet

https://doi.org/10.1186/s13287-019-1518-0

Similar Items